Sartorius reported EUR416.2M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Alaunos Therapeutics -1127000 1.11M Sep/2024
Avita Medical AUD 16.13M 3.05M Dec/2024
Dianthus Therapeutics 193K 970K Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Moderna USD 18M 1000K Jun/2025
Organon & Co USD 874M 33M Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Sartorius EUR 416.2M 14.8M Jun/2025
Tectonic Therapeutic 0 0 Mar/2025
Viatris USD 1.33B 98.1M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025